Results 311 to 320 of about 865,582 (335)

Renin-angiotensin system inhibitor use and risk of Parkinson's disease: a meta-analysis. [PDF]

Acta Neurol Belg
Xu TX, Jiang HY, Yang ZY.
europepmc   +1 more source

Use of renin-angiotensin system blockers and posttraumatic stress disorder risk in the UK Biobank: a retrospective cohort study. [PDF]

BMC Med
Kang S, Kim J, Yang JS, Jeon YJ, Lee HH, Suglia SF, Tsai AC, Kang JI, Jung SJ.   +8 more
europepmc   +1 more source

Renin-angiotensin system inhibitors and risk of hepatocellular carcinoma among patients with hepatitis B virus infection. [PDF]

CMAJ
Chen R, Zhou S, Liu J, Li L, Su L, Li Y, Fang C, Zhang X, Luo F, Gao Q, Lin Y, Guo Z, Cao L, Xu X, Nie S.   +14 more
europepmc   +1 more source

Does glycaemic control or renal function provide a better indicator for the service support required in type 1 diabetes?

Diabetic Medicine, EarlyView.
Adrian H. Heald, Mike Stedman, Edward Jude, Hellena Habte‐Asres, Angus Forbes, Martin Whyte, J. Martin Gibson, William Ollier   +7 more
wiley   +1 more source

Health Care Spending After Initiating Sacubitril-Valsartan vs Renin-Angiotensin System Blockers for Heart Failure Treatment.

JAMA Health Forum
Hwang CS, Desai RJ, Kesselheim AS, Levin R, Kattinakere Sreedhara S, Rome BN.   +5 more
europepmc   +1 more source

Brain and other central nervous system tumor statistics, 2021

Ca-A Cancer Journal for Clinicians, 2021
Carol Kruchko, Kristin A Waite, Kimberly D Miller   +2 more
exaly  

Radiation therapy‐associated toxicity: Etiology, management, and prevention

Ca-A Cancer Journal for Clinicians, 2021
Kyle Wang
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

Clinical characteristics, pathophysiology, and management of noncentral nervous system cancer‐related cognitive impairment in adults

Ca-A Cancer Journal for Clinicians, 2015
Jeffrey S Wefel, Shelli R Kesler, Sanne B Schagen   +2 more
exaly